Post-traumatic stress disorder.

Journal Article (Review)

In the past few years, there has been a growing interest in the neurobiology of PTSD. A number of models have been proposed including possible structural changes. We have now seen the appearance in the literature of controlled and double-blind trials. Of interest are positive outcome studies associated with the use of drugs with serotonergic actions for a period of 8 weeks. Symptom relief provided by pharmacotherapy enables the patient to participate more thoroughly in individual, behavioral, or group therapy.

Duke Authors

Cited Authors

  • Vargas, MA; Davidson, J

Published Date

  • December 1993

Published In

Volume / Issue

  • 16 / 4

Start / End Page

  • 737 - 748

PubMed ID

  • 8309810

Electronic International Standard Serial Number (EISSN)

  • 1558-3147

International Standard Serial Number (ISSN)

  • 0193-953X

Language

  • eng